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ABSTRACT
Background: Amphiregulin (AR) is expressed in Th2 cells, rather than Th1 cells, and plays an important role
in Th2 cellcytokine-mediated host defense against nematodes. We also found earlier that AR mRNA expres-
sion was strongly upregulated in inflamed tissue during Th2 cellcytokine-mediated fluorescein isothiocyanate
(FITC)-induced contact hypersensitivity (CHS), suggesting a contribution of AR to the induction of those re-
sponses.
Methods: To elucidate the role of AR in the induction of FITC- or dinitrofluorobenzene (DNFB)-induced CHS,
AR-deficient mice were sensitized andor challenged with FITC or DNFB epicutaneously. The levels of FITC-
mediated skin dendritic cell (DC) migration and FITC-specific lymph node cell proliferation and cytokine produc-
tion were assessed by flow cytometry, [3H]-thymidine incorporation and ELISA, respectively, after FITC sensiti-
zation. The degree of ear swelling, the activities of myeloperoxidase (MPO) and eosinophil peroxidase (EPO) in
inflammatory sites and the levels of FITC-specific immunoglobulin (Ig) in sera were determined by histological
analysis, colorimetric assay and ELISA, respectively, after FITC challenge.
Results: DC migration and FITC-specific lymph node cell proliferation and cytokine production were normal in
the AR-deficient mice. Ear swelling, tissue MPO and EPO activities and FITC-specific serum Ig levels were
also similar in AR-deficient and -sufficient mice.
Conclusions: Amphiregulin is not essential for the induction of FITC- or DNFB-induced CHS responses in
mice.
KEY WORDS
amphiregulin, contact dermatitis, EGF, mast cells, Th2 cellcytokine
INTRODUCTION
Contact hypersensitivity (CHS) responses, which are
induced by epicutaneous exposure to chemicals, are
classically considered to be an IFN-γ-producing Th1
and Tc1 cell-mediated allergic disorder.1 This is sup-
ported by the facts that increased levels of IFN-γ and
accumulation of IFN-γ+ Th1 cells were observed at lo-
cal inflammatory sites in CHS.2,3 However, results
from studies using IFN-γ- andor IFN-γR1-deficient
mice did not always support the concept, since they
showed normal development of CHS in response to
oxazolone4 and dinitrofluorobenzene (DNFB).5,6 CHS
induced by trinitrochlorobenzene (TNCB) in acetone
and olive oil developed normally in IFN-γ- and IFN-γR
1-deficient mice,4,7 while induction by TNCB in etha-
nol and acetone was attenuated in IFN-γ-deficient
mice.8 Although fluorescein isothiocyanate (FITC)-
induced CHS was attenuated in IFN-γR2-deficient
mice on a 129 × B6 mixed background,9 a normal re-
sponse was observed in IFN-γ-deficient mice on a C57
BL6 background.8,10 These observations suggest
that IFN-γ may not to be crucial for induction of CHS.
In contrast, it was shown that DNFB- andor TNCB-
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induced CHS responses were significantly decreased
in IL-4-deficient mice, while oxazolone-induced CHS
developed normally in those mutant mice.11-14 Al-
though IL-13-deficient mice showed normal develop-
ment of DNFB-induced CHS,15 STAT-6-deficient
mice, which lack both IL-4- and IL-13-mediated im-
mune responses, exhibited decreased inflammation
during DNFB-, TNCB-, oxazolone- and FITC-induced
CHS responses.16 Therefore, these observations indi-
cate that Th2 cytokinesTh2 cells, rather than Th1
cytokinesTh1 and Tc1 cells, are important in the
pathogenesis of CHS.
Recently, it was shown that amphiregulin (AR),
which is a member of the EGF family of growth fac-
torscytokines and involved in mammary gland devel-
opment and the progression of breast cancer,17,18 is
expressed in Th2 cells but not Th1 cells19 and plays
an important role in Th2 cell-mediated host defense
against nematodes.19 In addition, in our pilot study
using DNA microarrays, we found that expression of
AR mRNA was increased in local inflammatory sites
during Th2 cellcytokine-mediated FITC-induced
CHS. These observations suggest that AR produced
by Th2 cells andor other immune cells may contrib-
ute to the induction of CHS responses. However, the
precise role of AR in the pathogenesis of CHS is un-
known. In the present study, we used AR-deficient
mice and demonstrated that AR is not necessary for
FITC- or DNFB-induced CHS.
METHODS
MICE
Amphiregulin-deficient (AR--) mice on a 129 × B6
mixed background were originally generated as de-
scribed elsewhere.20 Littermates (AR++, AR+- and
AR-- mice) were used in all experiments. Mice were
housed under specific-pathogen-free conditions in the
National Research Institute for Child Health and De-
velopment, and the animal protocols were approved
by the Institutional Review Board of the National Re-
search Institute for Child Health and Development.
SKIN DC MIGRATION
Skin DC migration was determined as described else-
where.21 In brief, mice were epicutaneously treated
with 40 μl of 0.5% (wv) FITC isomer I solution in a
mixture of acetone and dibutylphthalate (1 : 1) (20 μl
to the surface of each left ear) and the vehicle alone
(20 μl to the surface of each right ear). Twenty-four
hours later, submaxillary lymph nodes (LNs) were
separately collected from both the FITC-treated left
and vehicle-treated right ears. LN single-cell suspen-
sions were prepared and incubated with anti-CD16
CD32 mAb (2.4 G2; BD Biosciences, San Jose, CA,
USA) on ice for 15 minutes for FcR blocking. Then
the cells were incubated with PE-anti-mouse CD11c
mAb (N418; eBioscience) and APC-anti-mouse I-AI-
E mAb (M5114.15.2; eBioscience, San Diego, CA,
USA). The proportion of FITC+ cells among 7-
aminoactinomycin D-negative, MHC class IIhi,
CD11c+ cells was determined using a FACS Calibur
(BD Biosciences).
FITC-SPECIFIC LN CELL RESPONSES
FITC-specific LN cell proliferative responses were
measured as described elsewhere.21 Briefly, mice
were sensitized with 2.0% FITC on both the left and
right ears (20 μl on one surface of each ear). Six days
later, submaxillary LNs were collected, and single-
cell suspensions were prepared. The LN cells were
cultured in the presence or absence of 40 μgml
FITC at 37℃ for 72 hours. FITC-specific LN cell pro-
liferative responses were determined by pulsing with
0.25 μCi [3H]-labeled thymidine for 6 hours.
MEASUREMENT OF CYTOKINES
Cytokine levels in the culture supernatants of FITC-
specific LN cells were determined with mouse IFN-γ,
IL-4, IL-10 and IL-17 ELISA kits obtained from BD Bi-
osciences or eBioscience.
INDUCTION OF CHS
FITC- or DNFB-induced CHS was induced as de-
scribed elsewhere.21-23 Briefly, 2 days after shaving
the back with clippers, mice were treated with 200 μl
of a 0.5 or 2.0% (wv) FITC isomer I (SIGMA) (0.5%
FITC solution and 2.0% FITC suspension, respec-
tively) in a mixture of acetone and dibutylphthalate
(1 : 1) or 25 μl of a 0.5% (vv) DNFB (Wako, Osaka,
Japan) in a mixture of acetone and olive oil (4 : 1).
Five days later, the animals were challenged with 40
μl of a 0.5% (wv) FITC isomer I solution in a mixture
of acetone and dibutylphthalate (1 : 1) (20 μl to the
surface of each left ear) and 40 μl of the vehicle alone
(20 μl to the surface of each right ear) or with 20 μl of
a 0.2% (vv) DNFB solution in a mixture of acetone
and olive oil (4 : 1) (the left ear) and 20 μl of the vehi-
cle alone (the right ear). Ear thickness was measured
before and after FITC challenge using an engineer’s
caliper (Ozaki MFG. Co. Ltd., Tokyo, Japan).
HISTOLOGY
Twenty-four hours after FITC challenge, ear tissues
were harvested, fixed in Carnoy’s fluid and embed-
ded in paraffin. Then sections were prepared and
stained with hematoxylin-eosin.
MEASUREMENT OF MYELOPEROXIDASE (MPO)
AND EOSINOPHIL PEROXIDASE (EPO) ACTIVI-
TIES
Twenty-four hours after FITC challenge, ear tissues
were harvested and homogenized in a 0.5% cetyl-
trimethylammonium chloride solution (Sigma-
Aldrich, St Louis, MO, USA). After passing the homo-
genates through a nylon mesh and centrifuging at
3,000 rpm for 20 minutes at 4℃, the supernatants
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Fig. 1 AR is not required for migration of FITC-bearing LCs/DCs from 
skin to draining LNs. At 24 hours after epicutaneous treatment with FITC 
(left ear skin) and vehicle (right ear skin), the submaxilary LNs on the left 
and right sides were separately colected. The proportion of FITC-positive 
cels among 7-aminoactinomycin D- MHC class Ihi CD11c+ cels was deter-
mined by flow cytometry. (A) Representative flow cytometry data. Shaded 
area = LNs draining vehicle-treated ears (lower number [%]); solid lines = 
LNs draining FITC-treated ears (upper number [%]). (B) Data show the 
mean + SEM of values for individual mice. Open columns = AR+/- mice (n = 
7), and solid columns = AR-/- mice (n = 8). **p < 0.01 vs. LNs draining 
vehicle-treated ears.
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were collected. For measurement of MPO activity,
the supernatants were diluted with 10 mM citrate
buffer (pH 5.0), followed by addition of an equal vol-
ume of substrate solution for MPO assay (3 mM
3,3',5,5'-tetramethylbenzidine (Sigma-Aldrich), 120
mM resorcinol (Wako), 2.2 mM H2O2 (Wako) in dis-
tilled water). For measurement of EPO activity, the
supernatants were diluted with 50 mM PIPES-NaOH
(pH 6.5) containing 6 mM KBr, followed by addition
of an equal volume of substrate solution for EPO as-
say (3 mM o-phenylenediamine (Sigma-Aldrich), 8.8
mM H2O2 (Wako) in 50 mM PIPES-NaOH (pH 6.5)
containing 6 mM KBr). After 0.5 to 2 minutes, 2N H2
SO4 was added to stop the reaction, and the absor-
bance was measured using a plate reader (MPO, 450
nm; EPO, 490 nm). The amount of total protein in ear
tissue homogenate was measured using a Bio-Rad
DC protein assay kit (Bio-Rad Laboratories, Hercules,
CA, USA). MPO and EPO activities were shown as
the absorbance per gram of total protein in ear tissue
homogenates.
MEASUREMENT OF FITC-SPECIFIC Ig LEVELS
Serum was collected from naïve mice and mice 8
days after FITC challenge during FITC-induced CHS
responses. FITC-conjugated OVA was prepared as
described elsewhere.21,24 A 96-well ELISA plate
(Nunc, 442404) was coated with 2 μgml FITC-OVA
at 4℃ overnight. After the wells were blocked with
PBS containing 10% FCS, optimally diluted serum
samples (IgG1, 11000; IgG2a, 110; IgG2b, 110;
IgG3, 110; and IgE, undiluted) were applied, and the
plates were incubated at room temperature for 1
hour. After washing, biotinylated anti-mouse IgG1 (A
85-1; BD Biosciences), IgG2a (R19-15; BD Bi-
osciences), IgG2b (R12-3; BD Biosciences), IgG3 (R
40-82; BD Biosciences) or IgE (R35-118; BD Bi-
osciences) mAb was added, followed by incubation at
room temperature for 1 hour. Then, after washing,
HRP-conjugated streptavidin (BD Biosciences) was
added, followed by incubation at room temperature
for 1 hour. For enzymatic reaction, TMB substrate
(KPL) was used as a substrate. The reaction was
stopped by addition of 2N H2SO4, and then the absor-
bance was measured using a plate reader at 450 nm.
Data show the absorbance value at 450 nm.
STATISTICAL ANALYSES
Data show the mean +± SEM. Differences were
evaluated by the two-tailed Student’s t test and con-
sidered significant at a P value of less than 0.05.
RESULTS
AMPHIREGULIN IS NOT ESSENTIAL FOR MI-
GRATION OF SKIN DENDRITIC CELLS FROM
SKIN TO DRAINING LNs AFTER EPICUTANE-
OUS FITC TREATMENT
Langerhans cells (LCs) and dermal dendritic cells
(DCs) are important in the sensitization and elicita-
tion phases of CHS. Activated keratinocyte-derived
cytokines such as IL-1 and TNF are crucial for migra-
tion of LCsdermal DCs from the skin to draining
LNs.2,3,7 AR can enhance activation of keratinocytes,25
implying the ability of AR to promote LCdermal DC
Yagami A et al.
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Fig. 2 AR deficiency did not influence FITC-specific LN 
cel responses. Mice were epicutaneously treated with 2.0% 
FITC on the ear skin. Six days later, submaxilary LN cels 
were colected and cultured in the presence and absence of 
40 μg/ml FITC for 72 hours. (A) Incorporation of [3H]-thymid-
ine and (B) the levels of IFN-γ, IL-4, IL-10 and IL-17 in the 
culture supernatants shown in (A) were determined. Data 
show the mean + SEM of values for individual mice. Open 
columns = AR+/- mice (n = 6), and solid columns = AR-/- mice 
(n = 6). *p < 0.05 and **p < 0.01 vs. LNs draining vehicle-
treated ears.
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Fig. 3 AR is not required for development of FITC- and 
DNFB-induced CHS. Five days after epicutaneous sensitiza-
tion with 0.5% (A), 2.0% FITC (B), and 0.5% DNFB (C), 
mice were chalenged with 0.5% FITC (A, B) or 0.2% DNFB 
(C) (left ears) and vehicle alone (right ears). Before (0) and 
after chalenge, ear thickness was measured using an engi-
neer’ scaliper. Data show the mean ± SEM of values for indi-
vidual mice. Open symbols = vehicle-treated ears, and 
closed symbols = FITC-treated ears. Diamonds = AR+/+ 
mice (A; n = 7, B; n = 9), squares = AR+/- mice (A; n = 21, B; 
n = 8, and C; n = 6) and circles = AR-/- mice (A; n = 22, B; 
n = 7, and C; n = 4). *p < 0.05 and **p < 0.01 vs. vehicle-
treated ears.
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migration. To assess the role of AR in skin LCDC
migration, we treated AR-deficient and -sufficient
mice with FITC epicutaneously. Twenty-four hours
after FITC treatment, the proportion of FITC-positive
cells among MHC class IIhi CD11c+ cells in draining
LNs was determined by flow cytometry. The propor-
tion of FITC-positive cells in draining LNs from AR-
deficient mice was equivalent to that from the litter-
mate control mice (Fig. 1). These results indicate that
AR is not essential for skin DC migration after epicu-
taneous FITC treatment.
AMPHIREGULIN IS NOT ESSENTIAL FOR DE-
VELOPMENT OF HAPTEN-SPECIFIC MEMORY T
CELLS
After hapten-carrying skin DCs migrate from skin to
draining LNs, these cells present the antigens to
naïve T cells and induce allergen-specific effector and
memory T cells in the sensitization phase of CHS.2,3
To elucidate the role of AR in hapten-specific memory
Amphiregulin in Contact Hypersensitivity
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Fig. 4 Inflammation is normal in AR-deficient mice during FITC-induced CHS. At 24 hours after FITC 
and vehicle treatment, ear tissues were colected and embedded in parafin. Sections of ear tissues were 
prepared and stained with hematoxylin and eosin. Representative data are shown. Scale bars = 100 μm.
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T-cell induction, draining LN cells from FITC-treated
mice were cultured in the presence of FITC in vitro.
FITC-specific LN cell proliferative responses evalu-
ated using [3H]-labeled thymidine were comparable
between AR-deficient and -sufficient mice (Fig. 2A).
The AR-deficient and -sufficient mice also showed
similar levels of IFN-γ, IL-4, IL-10 and IL-17 in their
LN cell culture supernatants (Fig. 2B). These obser-
vations indicate that AR is not important for the gen-
eration of hapten-specific T cells in the sensitization
phase of FITC-induced CHS.
AMPHIREGULIN IS NOT ESSENTIAL FOR DE-
VELOPMENT OF FITC-INDUCED CHS
It is known that Th2 cytokines such as IL-4 and IL-5
and mast cells are important for the development of
FITC-induced CHS.16,21 Moreover, in the microarray
analysis, we found that mRNA expression of AR was
increased 10.47-fold in FITC-challenged ears in com-
parison with vehicle-treated ears at 24 hours after the
treatment (n = 3, data not shown). These observa-
tions suggest that AR may be involved in the develop-
ment of FITC-induced CHS. However, AR-deficient
mice showed similar levels of ear swelling as com-
pared with AR-sufficient mice during both FITC- and
DNFB-induced CHS (Fig. 3). Also, histological analy-
sis found the same degree of inflammation in AR-
deficient and -sufficient mice at 24 hours after FITC
challenge (Fig. 4).
The inflammation in FITC-induced CHS was asso-
ciated with infiltration of neutrophils and eosino-
phils.16 We examined the activities of MPO and EPO
in the ear tissue homogenates at 24 hours after FITC
challenge. Consistently, MPO and EPO activities in
the ear tissue homogenates did not differ significantly
between the AR-deficient and -sufficient mice during
FITC-induced CHS (Fig. 5).
We next used ELISA to examine the levels of FITC-
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Fig. 5 MPO and EPO activities are normal in ear tissue ho-
mogenates from AR-deficient mice during FITC-induced 
CHS. At 24 hours after FITC and vehicle treatment, ear tis-
sues were colected and homogenates were prepared. The 
activities of MPO and EPO in ear tissue homogenates were 
determined by colorimetric assay. Data show the mean + 
SEM of values for individual mice. Open columns = AR+/- 
mice (n = 3), and solid columns = AR-/- mice (n = 3). *p < 
0.05 vs. vehicle-treated ears.
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Fig. 6 Levels of FITC-specific Igs are normal in sera from 
AR-deficient mice during FITC-induced CHS. Blood was col-
lected from naïve mice and mice 8 days after FITC 
chalenge. The levels of FITC-specific IgG1, IgG2a, IgG2b, 
IgG3 and IgE in sera were determined by ELISA. Data show 
the mean + SEM of values for individual mice. Open col-
umns = AR+/- mice (Naïve, n = 5; CHS, n = 8), and solid col-
umns = AR-/- mice (Naïve, n = 4; CHS, n = 7). *p < 0.05 and 
**p < 0.01 vs. naïve mice.
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specific Igs in sera from FITC-treated mice during
FITC-induced CHS. The levels of FITC-specific IgG1,
IgG2a, IgG2b, IgG3 and IgE in sera from AR-deficient
mice were equal to those from AR-sufficient mice af-
ter FITC challenge (Fig. 6). Taken all together, these
results indicate that AR is not essential for the devel-
opment of FITC-induced CHS.
DISCUSSION
AR, a member of the EGF family of growth factors
cytokines, plays an important role in the enhance-
ment andor inhibition of cell growth and is involved
in physiological responses such as mammary gland
development, blastocyst implantation, bone formation
and nerve regeneration as a growth factor.17,18 As an-
other functional aspect of AR, it was shown that Th2
cell-derived AR is involved in the pathogenesis of Th2
cellcytokine-mediated host defense against nema-
todes.19 In addition, we and others have demon-
strated that mast cells can produce AR by IgE-FcεRI
crosslinking, and AR enhanced not only mucin gene
expression in human epithelial cells but also prolif-
eration of human lung fibroblasts,26,27 implying a con-
tribution of AR to the pathogenesis of Th2 cell
cytokine- and mast cell-mediated immune responses,
such as allergic diseases.
CHS is classically considered to be an IFN-γ-
producing Th1- and Tc1-mediated allergic disease of
the skin.1 However, Th2 cellscytokines rather than
Th1Tc1 cellscytokines seemed to be potentially re-
sponsible for the development of CHS.10,28 In particu-
lar, Th2 cytokines and mast cells are responsible for
the development of CHS induced by FITC.16,21 These
observations suggest that AR may be involved in the
development of Th2 cellcytokine- and mast cell-
associated CHS.
In the sensitization phase of CHS, activation of skin
LCsDCs is considered to be important for induction
of hapten-specific effectormemory T cells.2,3
Keratinocyte-derived proinflammatory cytokines such
as TNF and IL-1 are crucial for LCDC migration and
maturation.2,3,7 Since AR can enhance activation of
keratinocytes,25 it might be expected to play a role in
that step during CHS. However, we found that the
levels of skin DCLC migration and the proliferation
and cytokine production of hapten-stimulated LN
cells were normal in AR-deficient mice. These obser-
vations indicate that AR is not crucial for migration of
LCsDCs from the skin into draining LNs or for in-
duction of hapten-specific effectormemory T cells in
the sensitization phase of CHS.
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In the elicitation phase of CHS induced by FITC,
we found (by DNA microarray analysis) that AR
mRNA expression was approximately 10-fold in-
creased in FITC-challenged ear skin at 24 hours after
treatment in comparison with vehicle-treated ear
skin. However, local inflammation, assessed by ear
swelling, histological analysis and the levels of MPO
and EPO activities in tissue homogenates at 24 hours
after the FITC challenge, and the levels of hapten-
specific serum Igs were also comparable between AR-
deficient and -sufficient mice. Therefore, AR is not
necessary for induction of inflammation in the elicita-
tion phase of CHS.
Taken all together, we conclude that AR is not es-
sential for the development of FITC-induced CHS in
mice.
ACKNOWLEDGEMENTS
We thank Shuhei Fukuda, Hiromi Wakita, Michiko
Yamada, Akina Ishii and Noriko Hashimoto for their
excellent technical assistance, Akane Nakamura for
animal care, and Dr. David Lee for providing
amphiregulin-deficient mice. This work was sup-
ported by a grant to H.S. from the National Institute
of Biomedical Innovation and by Grants-in-Aid for
Young Scientists (B) to N.K., K.O. and S.N., and by
the Program for Improvement of Research Environ-
ment for Young Researchers, The Special Coordina-
tion Funds for Promoting Science and Technology to
S.N. from the MEXT, Japan and supported by grant
CA43793 from the U.S. National Institutes of Health
(S.W.S.).
REFERENCES
1. Wang B, Fujisawa H, Zhuang L et al. CD4+ Th1 and CD8+
type 1 cytotoxic T cells both play a crucial role in the full
development of contact hypersensitivity. J Immunol 2000;
165:6783-90.
2. Grabbe S, Schwarz T. Immunoregulatory mechanisms in-
volved in elicitation of allergic contact hypersensitivity.
Immunol Today 1998;19:37-44.
3. Kimber I, Dearman RJ. Allergic contact dermatitis: the
cellular effectors. Contact Dermatitis 2002;46:1-5.
4. Saulnier M, Huang S, Aguet M, Ryffel B. Role of
interferon-γ in contact hypersensitivity assessed in
interferon-γ receptor-deficient mice. Toxicology 1995;102:
301-12.
5. Dhabhar FS, Satoskar AR, Bluethmann H, David JR,
McEwen BS. Stress-induced enhancement of skin im-
mune function: A role for γ interferon. Proc Natl Acad Sci
U S A 2000;97:2846-51.
6. Reeve VE, Bosnic M, Nishimura N. Interferon-γ is in-
volved in photoimmunoprotection by UVA (320-400 nm)
radiation in mice. J Invest Dermatol 1999;112:945-50.
7. Nakae S, Komiyama Y, Narumi S et al. IL-1-induced tu-
mor necrosis factor-α elicits inflammatory cell infiltration
in the skin by inducing IFN-γ-inducible protein 10 in the
elicitation phase of the contact hypersensitivity response.
Int Immunol 2003;15:251-60.
8. Mori T, Kabashima K, Yoshiki R et al. Cutaneous hyper-
sensitivities to hapten are controlled by IFN-γ-upregulated
keratinocyte Th1 chemokines and IFN-γ-downregulated
langerhans cell Th2 chemokines. J Invest Dermatol 2008;
128:1719-27.
9. Lu B, Ebensperger C, Dembic Z et al. Targeted disruption
of the interferon-γ receptor 2 gene results in severe im-
mune defects in mice. Proc Natl Acad Sci U S A 1998;95:
8233-8.
10. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Al-
lergol Int 2008;57:121-34.
11. Berg DJ, Leach MW, Kuhn R et al. Interleukin 10 but not
interleukin 4 is a natural suppressant of cutaneous inflam-
matory responses. J Exp Med 1995;182:99-108.
12. Dieli F, Sireci G, Scire E, Salerno A, Bellavia A. Impaired
contact hypersensitivity to trinitrochlorobenzene in
interleukin-4-deficient mice. Immunology 1999;98:71-9.
13. Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N. Inhi-
bition of allergic contact dermatitis to DNCB but not to
oxazolone in interleukin-4-deficient mice. J Invest Derma-
tol 1999;112:476-82.
14. Weigmann B, Schwing J, Huber H et al. Diminished con-
tact hypersensitivity response in IL-4 deficient mice at a
late phase of the elicitation reaction. Scand J Immunol
1997;45:308-14.
15. Herrick CA, Xu L, McKenzie AN, Tigelaar RE, Bottomly
K. IL-13 is necessary, not simply sufficient, for epicutane-
ously induced Th2 responses to soluble protein antigen. J
Immunol 2003;170:2488-95.
16. Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB.
Essential role of MHC II-independent CD4+ T cells, IL-4
and STAT6 in contact hypersensitivity induced by fluo-
rescein isothiocyanate in the mouse. Int Immunol 2004;
16:685-95.
17. McBryan J, Howlin J, Napoletano S, Martin F. Am-
phiregulin: role in mammary gland development and
breast cancer. J Mammary Gland Biol Neoplasia 2008;13:
159-69.
18. Willmarth NE, Ethier SP. Amphiregulin as a novel target
for breast cancer therapy. J Mammary Gland Biol Neopla-
sia 2008;13:171-9.
19. Zaiss DM, Yang L, Shah PR, Kobie JJ, Urban JF, Mos-
mann TR. Amphiregulin, a TH2 cytokine enhancing resis-
tance to nematodes. Science 2006;314:1746.
20. Luetteke NC, Qiu TH, Fenton SE et al. Targeted inactiva-
tion of the EGF and amphiregulin genes reveals distinct
roles for EGF receptor ligands in mouse mammary gland
development. Development 1999;126:2739-50.
21. Suto H, Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli
SJ. Mast cell-associated TNF promotes dendritic cell mi-
gration. J Immunol 2006;176:4102-12.
22. Zabel BA, Nakae S, Zuniga L et al. Mast cell-expressed or-
phan receptor CCRL2 binds chemerin and is required for
optimal induction of IgE-mediated passive cutaneous ana-
phylaxis. J Exp Med 2008;205:2207-20.
23. Nakae S, Komiyama Y, Nambu A et al. Antigen-specific T
cell sensitization is impaired in IL-17-deficient mice, caus-
ing suppression of allergic cellular and humoral re-
sponses. Immunity 2002;17:375-87.
24. Lutz MB, Assmann CU, Girolomoni G, Ricciardi-
Castagnoli P. Different cytokines regulate antigen uptake
and presentation of a precursor dendritic cell line. Eur J
Immunol 1996;26:586-94.
25. Piepkorn M, Pittelkow MR, Cook PW. Autocrine regula-
tion of keratinocytes: the emerging role of heparin-
binding, epidermal growth factor-related growth factors. J
Invest Dermatol 1998;111:715-21.
26. Okumura S, Sagara H, Fukuda T, Saito H, Okayama Y.
Yagami A et al.
284 Allergology International Vol 59, No3, 2010 www.jsaweb.jp
FcεRI-mediated amphiregulin production by human mast
cells increases mucin gene expression in epithelial cells. J
Allergy Clin Immunol 2005;115:272-9.
27. Wang SW, Oh CK, Cho SH et al. Amphiregulin expres-
sion in human mast cells and its effect on the primary hu-
man lung fibroblasts. J Allergy Clin Immunol 2005;115:
287-94.
28. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-
17A in inflammatory immune responses and host defense
against pathogens. Immunol Rev 2008;226:57-79.
